RNA5SP528

Across TCGA pan-cancer cohorts, RNA5SP528 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNA5SP528 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RNA5SP528 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP528 expression acts as an unfavorable survival marker, although some lineages such as UCS and SKCM show a favorable association.

COAD, CESC, and LIHC are the cancer types where RNA5SP528 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	IV	0.114	0.668	<.001	36	view →
CESC	OS	Tertile	All	0.315	0.606	.007	24	view →
LIHC	DFS	Tertile	All	0.147	0.544	<.001	24	view →
UCS	DFS	Tertile	II,III,IV	0.657	0.309	.007	18	view →
READ	DFS	Tertile	IV	0.027	0.636	<.001	18	view →
LUAD	OS	Tertile	III,IV	0.300	0.526	.046	9	view →
SKCM	DFS	Tertile	All	0.309	0.179	.009	6	view →
LGG	DFS	Tertile	All	0.549	0.771	.019	6	view →
OV	DFS	Tertile	All	0.580	0.514	.037	4	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNA5SP528–COAD (OS)

Open the COAD breakdown →